Deng Chao, An Yulong, Liu Jinli, Wang Chao, Gou Haoxian, Zhang Jinpeng, Gu Minghui, Li Mengmeng, Wang Tao, Luo Hao
Department of General Surgery, The General Hospital of Western Theater Command, Chengdu, China.
Clinical Medicine College of Southwest Medical University, Luzhou, Sichuan, China.
Front Oncol. 2025 May 16;15:1522002. doi: 10.3389/fonc.2025.1522002. eCollection 2025.
Hepatic epithelioid hemangioendothelioma (HEHE) is classified as a rare, low-grade malignant neoplasm of vascular origin. This study presents a case report of a young female patient recently diagnosed with HEHE. A comprehensive review of the current understanding of HEHE is provided, along with the implementation of a novel combination treatment approach based on contemporary knowledge of this rare hepatic malignancy.
A 22-year-old female patient, with no prior medical history, underwent a routine health examination five months prior to presentation. Multiple space-occupying lesions in the liver were incidentally detected through ultrasound imaging, despite the patient being asymptomatic. Subsequent positron emission tomography-computed tomography (PET-CT) examination suggested the possibility of benign lesions. Recent follow-up examinations revealed no further progression of the lesions; however, a biopsy of the lesions confirmed the diagnosis of HEHE. Comprehensive imaging studies, including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), demonstrated scattered space-occupying lesions throughout the liver, with no evidence of distant metastasis. To minimize surgical trauma and preserve liver function, a multidisciplinary team was consulted, and a treatment plan was devised: liver resection in combination with microwave ablation of the lesions. The patient's postoperative recovery was uneventful, leading to successful hospital discharge.
HEHE is characterized by its insidious onset and rarity, often presenting with multiple lesions at the time of clinical diagnosis. While liver transplantation may be considered the optimal treatment for multifocal HEHE, in cases where transplantation is not feasible, the combination of liver resection and microwave ablation of lesions may represent a safe and effective alternative therapeutic approach.
肝上皮样血管内皮瘤(HEHE)被归类为一种罕见的、低级别血管源性恶性肿瘤。本研究报告了一名近期被诊断为HEHE的年轻女性患者的病例。本文在提供对HEHE当前认识的全面综述的同时,还基于对这种罕见肝脏恶性肿瘤的当代知识,实施了一种新的联合治疗方法。
一名22岁的女性患者,既往无病史,在就诊前五个月接受了一次常规健康检查。尽管患者无症状,但通过超声成像偶然发现肝脏有多个占位性病变。随后的正电子发射断层扫描 - 计算机断层扫描(PET - CT)检查提示病变可能为良性。近期的随访检查显示病变无进一步进展;然而,病变活检确诊为HEHE。包括超声、计算机断层扫描(CT)和磁共振成像(MRI)在内的综合影像学研究表明,肝脏内散在占位性病变,无远处转移迹象。为尽量减少手术创伤并保留肝功能,咨询了多学科团队并制定了治疗方案:肝切除联合病变微波消融。患者术后恢复顺利,成功出院。
HEHE具有起病隐匿和罕见的特点,临床诊断时通常表现为多个病变。虽然肝移植可能被认为是多灶性HEHE的最佳治疗方法,但在移植不可行的情况下,肝切除联合病变微波消融可能是一种安全有效的替代治疗方法。